735,619 Shares in Strata Critical Medical $SRTA Purchased by CenterBook Partners LP

Key Points

• CenterBook Partners LP acquired 735,619 shares of Strata Critical Medical in the third quarter, worth about $3.76 million and representing approximately 0.83% of the company. Institutional investors collectively own 47.36% of its shares.
• Strata reported a quarterly loss of $0.09 per share, missing analyst expectations for earnings of $0.01 per share; quarterly revenue was $74.08 million.
• Analysts’ average rating is Moderate Buy, with an average price target of $8.00. Shares opened at $5.56 and were reported up 5.7%.

CenterBook Partners LP purchased a new stake in Strata Critical Medical (NASDAQ:SRTA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 735,619 shares of the company's stock, valued at approximately $3,759,000. CenterBook Partners LP owned approximately 0.83% of Strata Critical Medical as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State of Wyoming acquired a new stake in shares of Strata Critical Medical in the third quarter worth $67,000. Fifth Third Wealth Advisors LLC purchased a new stake in Strata Critical Medical in the 3rd quarter worth about $138,000. Cyndeo Wealth Partners LLC acquired a new stake in Strata Critical Medical during the 3rd quarter worth about $82,000. Sax Wealth Advisors LLC acquired a new stake in Strata Critical Medical during the 3rd quarter worth about $71,000. Finally, Farther Finance Advisors LLC boosted its position in Strata Critical Medical by 336.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 6,618 shares of the company's stock worth $34,000 after acquiring an additional 5,101 shares during the period. Institutional investors and hedge funds own 47.36% of the company's stock.

Insider Transactions at Strata Critical Medical

In other Strata Critical Medical news, Director Reginald Love sold 5,091 shares of the business's stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $5.75, for a total value of $29,273.25. Following the transaction, the director owned 146,481 shares in the company, valued at $842,265.75. The trade was a 3.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 15.50% of the company's stock.

Strata Critical Medical Stock Up 5.7%

Shares of NASDAQ:SRTA opened at $5.56 on Friday. The firm has a fifty day moving average of $4.99 and a two-hundred day moving average of $5.21. The firm has a market capitalization of $491.89 million, a P/E ratio of -139.00 and a beta of 2.56. Strata Critical Medical has a 12-month low of $3.95 and a 12-month high of $6.50.

Strata Critical Medical (NASDAQ:SRTA - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by ($0.10). Strata Critical Medical had a negative return on equity of 2.71% and a negative net margin of 8.84%. The company had revenue of $74.08 million during the quarter. Equities research analysts expect that Strata Critical Medical will post -0.12 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Strata Critical Medical in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Strata Critical Medical has an average rating of "Moderate Buy" and an average target price of $8.00.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.